Product Information
OLANZAPINE 10 MG VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $20.9230 per EA under NDC 00143919901. Its NADAC has been published 49 times since Oct 29, 2025.
FDA first approved this application on May 16, 2025. Its Orange Book therapeutic-equivalence code is AP.
Strength
10 mg/2mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143919901
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
OLANZAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA218116FDA Approved
5/16/2025
TE Code
AP
On Market Since
9/18/2025
Pharmacological Classes
Price Statistics
The NADAC for OLANZAPINE 10 MG VIAL has been published 49 times since Oct 29, 2025, and over the history we have for it it has declined 12.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $20.9230 per EA |
|---|---|
| All-time high | $23.8100 (Apr 15, 2026) |
| All-time low | $20.9230 (Sep 23, 2026) |
| 52-week high | $23.8100 |
| 52-week low | $20.9230 |
| Median price | $23.8100 |
| Average price | $22.8032 |
| Largest weekly change | -8.1% (Apr 22, 2026) |
| Weeks tracked | 49 |
| Tracking since | Oct 29, 2025 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Olanzapine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OLANZAPINE 10 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for OLANZAPINE 10 MG VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $20.9230 per EA (NDC 00143919901), effective Sep 30, 2026.
How has the price of OLANZAPINE 10 MG VIAL changed over time?
Over the history we have for it, the NADAC for OLANZAPINE 10 MG VIAL has declined 12.1%. It has been tracked across 49 weekly CMS publications since Oct 29, 2025.
What are the highest and lowest recorded NADAC prices for OLANZAPINE 10 MG VIAL?
Since Oct 29, 2025, the NADAC for OLANZAPINE 10 MG VIAL has ranged from a low of $20.9230 (Sep 23, 2026) to a high of $23.8100 (Apr 15, 2026), with a median of $23.8100 per EA.
Are there cheaper alternatives to OLANZAPINE 10 MG VIAL?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OLANZAPINE 10 MG VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures OLANZAPINE 10 MG VIAL?
OLANZAPINE 10 MG VIAL (NDC 00143919901) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.